| 2013 | Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation | RADIOTHERAPY AND ONCOLOGY |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| ONCOTARGET |
| 2001 | Design and Synthesis of Fluoroquinophenoxazines That Interact with Human Telomeric G-Quadruplexes and Their Biological Effects
| MOLECULAR CANCER THERAPEUTICS |
| 2021 | Detection of asymptomatic recurrence improves survival of gastric cancer patients
| CANCER MEDICINE |
| 2005 | Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray
| CLINICAL CANCER RESEARCH |
| 2020 | Development and evaluation of the Cancer Symptom Management System: Symptom Management Improves your LifE (SMILE)-a randomized controlled trial | SUPPORTIVE CARE IN CANCER |
| 2021 | Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
| GUT |
| 2013 | Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice | MELANOMA RESEARCH |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
| 1998 | Different expression patterns of MMP-2 and MMP-9 in breast cancer | ONCOLOGY REPORTS |
| 2005 | Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction
| FEBS LETTERS |
| 2017 | Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma | APMIS |
| 2012 | Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. | EXPERIMENTAL AND MOLECULAR PATHOLOGY |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
| 2017 | Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma | CLINICAL GENITOURINARY CANCER |
| 2024 | Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma | BIOORGANIC CHEMISTRY |
| 2008 | Disease Prediction Using Ranks of Gene Expressions
| Genomics & Informatics |
| 2012 | Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
| CANCER |
| 2009 | DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
| BRITISH JOURNAL OF CANCER |
| 2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
| 2022 | Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 | JOURNAL OF CLINICAL ONCOLOGY |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2014 | Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial. | LANCET ONCOLOGY |
| 2024 | Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
| NATURE COMMUNICATIONS |
| 2022 | Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
| CANCER DISCOVERY |
| 2011 | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | SUPPORTIVE CARE IN CANCER |
| 2009 | Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2000 | Effect of telomere and telomerase interactive agents on human tumor and normal cell lines
| Clinical Cancer Research |
| 1999 | Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector | ONCOLOGY REPORTS |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2013 | Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2022 | Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial | JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial | INTERNATIONAL JOURNAL OF CANCER |
| 2022 | Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052 | ANNALS OF ONCOLOGY |
| 2018 | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | GASTRIC CANCER |
| 2016 | Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08
| CANCER RESEARCH AND TREATMENT |
| 2014 | Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency | EUROPEAN JOURNAL OF CANCER |
| 2011 | Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis | ONCOLOGY |
| 2015 | Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series
| BMC CANCER |
| 2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| CANCER RESEARCH AND TREATMENT |
| 2012 | EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
| YONSEI MEDICAL JOURNAL |
| 2022 | Enhanced supportive care for advanced cancer patients: study protocol for a randomized controlled trial
| BMC NURSING |
| 2007 | Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2019 | EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
| BMC CANCER |
| 2022 | Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
| GUT |
| 2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
| NATURE COMMUNICATIONS |
| 2017 | Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma | CANCER DISCOVERY |
| 2016 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
| ONCOTARGET |
| 2016 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial | LANCET |
| 2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | JOURNAL OF SURGICAL ONCOLOGY |
| 2013 | Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
| BRITISH JOURNAL OF CANCER |
| 2012 | Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes | NATURE GENETICS |
| 2013 | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study | LANCET ONCOLOGY |
| 2012 | External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer
| ANNALS OF ONCOLOGY |
| 2004 | Fabrication of high quality cDNA microarray using a small amount of cDNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 2022 | Fear of cancer recurrence and its predictors and outcomes among cancer survivors: A descriptive correlational study | EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2013 | Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| YONSEI MEDICAL JOURNAL |
